Free Trial

Victory Capital Management Inc. Increases Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Privia Health Group logo with Medical background
Remove Ads

Victory Capital Management Inc. boosted its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 62.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 290,009 shares of the company's stock after buying an additional 110,960 shares during the quarter. Victory Capital Management Inc. owned 0.24% of Privia Health Group worth $5,670,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of the company. First Horizon Advisors Inc. grew its holdings in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after purchasing an additional 632 shares during the last quarter. Financial Management Professionals Inc. purchased a new position in shares of Privia Health Group during the fourth quarter valued at approximately $51,000. Quarry LP grew its stake in shares of Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company's stock valued at $60,000 after buying an additional 2,533 shares during the last quarter. KBC Group NV raised its holdings in shares of Privia Health Group by 34.6% in the third quarter. KBC Group NV now owns 3,385 shares of the company's stock worth $62,000 after buying an additional 871 shares during the period. Finally, Neo Ivy Capital Management bought a new stake in shares of Privia Health Group during the 3rd quarter worth approximately $66,000. Institutional investors own 94.48% of the company's stock.

Privia Health Group Trading Up 0.3 %

Shares of NASDAQ:PRVA traded up $0.08 during trading on Wednesday, reaching $23.70. The stock had a trading volume of 283,464 shares, compared to its average volume of 750,646. The firm's 50-day simple moving average is $23.49 and its 200 day simple moving average is $20.96. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $26.04. The company has a market capitalization of $2.86 billion, a P/E ratio of 237.12, a PEG ratio of 3.47 and a beta of 0.85.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities analysts have commented on PRVA shares. Piper Sandler upped their price objective on Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a research report on Friday, February 28th. Canaccord Genuity Group upped their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a report on Friday, February 28th. JMP Securities set a $29.00 price objective on shares of Privia Health Group in a report on Friday, February 28th. Needham & Company LLC upped their target price on shares of Privia Health Group from $25.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. Finally, Stephens reaffirmed an "overweight" rating and set a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Privia Health Group presently has an average rating of "Buy" and an average target price of $26.67.

Read Our Latest Stock Report on PRVA

About Privia Health Group

(Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Read More

Institutional Ownership by Quarter for Privia Health Group (NASDAQ:PRVA)

Should You Invest $1,000 in Privia Health Group Right Now?

Before you consider Privia Health Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.

While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads